Medical Device Market Approval & Certification

In Vitro Diagnostic Regulation (IVDR)

Achieve EU market access for in vitro diagnostic medical devices.

Achieve EU market access for in vitro diagnostic medical devices.

What is the In Vitro Diagnostic Regulation (IVDR)?

The In Vitro Diagnostic Regulation (IVDR) is the current European Union (EU) regulatory legislation for placing in-vitro diagnostic devices on the EU market, making them available and putting them into service.

The IVDR regulation was published in the Official Journal of the EU on 5 May 2017, and entered into force on 26 May 2017, gradually replacing the EU’s former Directive on in vitro diagnostic medical devices (98/79/EC).

As a European regulation, it is effective in all EU member states and EFTA states immediately without needing to be transposed into the law of respective states. However, national laws may be adapted to back up some requirements in more detail.

Request for an IVDR Service Registration today

Download the IVDR Service Description

 

Key IVD amendments

Four additional regulations have been enacted with the primary purpose of providing adequate time and resources to ensure continued availability of devices on the EU market.

  Regulation

         Key Provisions

  (EU) 2022/112

  • First extension of transitional provisions for legacy devices
  • Introduction of staggered transition periods based on device classification

  (EU) 2023/503

  • Extension of the frequency of reassessment of notified bodies

  (EU) 2023/607

  • Removal of the sell-off period for devices placed on the market during the transition period

  (EU) 2024/1860

  • Second extension of transitional provisions
  • Addition of timelines for implementation of an IVDR-compliant quality system
  • Addition of timelines for application to and completion of a signed agreement with a notified body
  • Phased roll-out of the European Database on Medical Devices (EUDAMED)
  • Introduction of an obligation to notify an anticipated discontinuation of supply of devices

 

IVDR Transition Timeline

Only “legacy” devices meeting the following conditions can benefit from the IVDR transition timelines:

a) those devices continue to comply with Directive 98/79/EC;
b) there are no significant changes in the design and intended purpose;
c) the devices do not present an unacceptable risk to the health or safety of patients, users or other persons, or to other aspects of the protection of public health;

The transition period depends on the classification of the device and whether it was CE-marked under the IVDD by self-declaration or by certification with a Notified Body. The following timelines apply:

  • Devices with an IVDD certificate
    • 26 May 2025 – Implement IVDR-compliant quality system
    • 26 May 2025 – Apply to a notified body
    • 26 September 2025 – Conclude a written agreement with a notified body
    • 31 December 2027 – End of transition period
  • Class D devices
    • 26 May 2025 – Implement IVDR-compliant quality system
    • 26 May 2025 – Apply to a notified body
    • 26 September 2025 – Conclude a written agreement with a notified body
    • 31 December 2027 – End of transition period
  • Class C devices
    • 26 May 2025 – Implement IVDR-compliant quality system
    • 26 May 2026 – Apply to a notified body
    • 26 September 2026 – Conclude a written agreement with a notified body
    • 31 December 2028 – End of transition period
  • Class B devices
    • 26 May 2025 – Implement IVDR-compliant quality system
    • 26 May 2027 – Apply to a notified body
    • 26 September 2027 – Conclude a written agreement with a notified body
    • 31 December 2029 – End of transition period
  • Class A sterile devices
    • 26 May 2025 – Implement IVDR-compliant quality system
    • 26 May 2027 – Apply to a notified body
    • 26 September 2027 – Conclude a written agreement with a notified body
    • 31 December 2029 – End of transition period

  • Class A (non-sterile) devices
    Transition period does not apply – full compliance required as of 26 May 2022

You must apply to the Notified Body (NB) by the dates listed below. You must then sign a contract with an NB by 26th September of the respective years. Your products can then continue to be placed on the market until the end of the transition period, as indicated below, depending on the Class of your devices.

For all legacy devices, certain requirements of the IVDR regulation, including post-market surveillance, vigilance, registration of economic operators, and market surveillance are applicable since the date of application of the IVDR (May 26, 2022) as per article 110 (3).

See the infographic below for a summary of the timeline of IVDR Transitional Provisions:
PPT-MHS tuvsud-ivdr-transition-timeline-desktop2

 

How you Can prepare

  • Ensure that your quality management system complies with the requirements of IVDR Article 10(8)
  • Prepare your technical documentation in accordance with IVDR Annex II & III
    • Assess whether existing information (e.g. from IVDD or ex-EU applications) is adequate to demonstrate compliance 
    • Generate required data to address any gaps 
    • Refer to our best practice guide for IVDR technical documentation 
  • Engage with us early on to discuss your needs
    • Our Structured Dialogue provides an opportunity to discuss the procedural and regulatory requirements with us before lodging your application for IVDR conformity assessment  
  • Keep informed about new regulations and guidance

 

How TÜV SÜD Can Help You with the IVDR

As one of the world’s largest EU Notified Bodies for all types of medical devices covered by EU directives and regulations, TÜV SÜD is designated as a full-scope Notified Body under the IVDR regulation.

Our experts’ experience and expertise make TÜV SÜD your trusted service provider for the certifications required to place your in-vitro diagnostic devices to the EU market, providing a full range of certification and testing services for global market access.

We work collaboratively with our partners to ensure access to critical innovative diagnostic technologies for patients and providers.

 

STRUCTURED DIALOGUE

The complex development process for most types of medical devices, combined with the need to address new regulatory requirements and obtain Notified Body approval, is likely to make the transition a complicated and time-consuming process for most device manufacturers. Further, previously approved devices are not exempt from the new regulation's requirements and will need to be re-evaluated and re-approved.

The purpose of a structured dialogue prior to lodging a formal IVDR application with TÜV SÜD is to clarify the timing, procedural, and regulatory aspects of the application process and forms, and the submission documents.

These structured dialogues are an opportunity to meet with us before the application for a conformity assessment and are independent of the assessment.

Expand the tabs below to find out the possible topics, process and how to apply for Structured Dialogue.

  • Possible topics for Structured Dialogue

    Application & Onboarding

    • Onboarding process
    • Application forms & review process
    • Sites, suppliers & devices
    • Device classification & code assignment

    Topics of manufacturer

    • TÜV SÜD Testing & Certification Regulations
    • IVDR Framework Agreement
    • Handling of device and other changes
    • Transfer to TÜV SÜD Notified Body

    Conformity Assessment Procedure

    • Project planning, time limits special procedures (e.g. consultation)
    • Submission requirements
    • Costs, fees & other financial aspects
    • CS, guidance documents & harmonised standards
  • Structured Dialogue process
    MHS tuvsud-structured-dialogue-process-desktop
  • How can I apply for Structured Dialogue

    Existing clients with TÜV SÜD Notified Body:

    • If you are an existing client, please get in touch with your dedicated client manager to move forward.

    Potential clients with IVDR Transition Timeline:

    • If you wish to engage TÜV SÜD as a Notified Body and kickstart the Structured Dialogue, please request a reachout.

    Request a Reachout

 

 

Get Started with TÜV SÜD

Request our services for your IVDR needs. Start your journey with us.      Request a reachout


ivdr application procedure

Based on the product classification, the manufacturer must apply for an applicable conformity assessment procedure.

Contact us using our simple service request form to initiate your application process.

English and/or German are the only acceptable languages for the submission of documentation and any related correspondence.

tuvsud-conformity-assessment-procedures-under-ivdr-desktop_page1

IVDR resources

Ensure a smooth process of complying with the IVDR with the following resources.


Audit Checklists

 

IVDR QM System Requirements

This checklist will help manufacturers and the audit team prepare for the audit and see where the requirements are fulfilled or described.

Download

 

 

IVDR Technical Documentation Submission Requirements

This checklist will help you prepare the technical documentation for submission to the notified body.

Download

Certification Guidance Documents

 

Extended IVDR Transition timelines 

Here’s a quick guide on the IVDR timelines.

Download  

 

IVDR Sampling

Understand how TÜV SÜD implements the requirements of   sampling for Class B     and Class C devices under the IVDR. Review additional practical explanations and implications.

Download

 

 

Legacy Products under IVDR

Here’s information on how products that are already on the market under the old In Vitro Diagnostic Directive (IVDD) can transition to IVDR.

Download

 

IVDR Companion Diagnostics (CDx)

Find out how you can successfully complete IVDR certification for CDx devices.

Download

Additional Infosheets

 

The European In Vitro Diagnostic Medical Device Regulation (IVDR)

This infosheet provides an overview of the IVDR and what you need to do.

Download

 

 

IVDR Class D

This infosheet provides information on the provisions for special scrutiny of high-risk Class D devices.

Download

 

 

IVDR Classification

This infosheet provides information on medical device classification under the IVDR (EU) 2017/746.

Download

EXPLORE

Legacy Products Under IVDR
信息表

Legacy devices under IVDR

IVDR replaces IVDD with phased implementation.

Download now

Quality Management System Requirements under IVDR 2017/746
信息表

IVDR QM System Requirements

Ensure IVDR QMS compliance and audit readiness.

Download now

Technical Documentation
信息表

IVDR Technical Documentation submission requirements.

Learn Technical Documentation submission requirements.

Download Now

IVDR Sampling Infosheet
信息表

IVDR Sampling Infosheet

Get an overview of IVDR sampling for Class B and C devices' technical documentation.

Download now

IVDR CDx infosheet
信息表

IVDR Companion Diagnostix CDx Infosheet

Learn about IVDR CDx certification and the consultation process.

Download now

IVDR Class D Devices Infosheet
信息表

IVDR Class D Devices Infosheet

Discover the European Regulation on in vitro diagnostic medical devices (EU) 2017/746 (IVDR) with provisions for special scrutiny of high-risk Class D devices.

Learn More

Extended IVDR_transition_timelines
信息表

Extended IVDR Transition Timelines

Learn about extension of the IVDR Transition Period Under Regulation (EU) 2024/1860.

Download now

 EU IVDR
信息表

The European In Vitro Diagnostic Medical Device Regulation IVDR

Learn about the IVDR and its device classification.

Download now

IVDR Classification infosheet
信息表

IVDR Classification Infosheet

Learn IVDR risk-based classification for medical devices.

Download now

VIEW ALL RESOURCES

更多

LinkedIn WeChat WeChat

Site Selector